Many trials that measure the efficacy and safety of antidepressants for MDD exclude one third of real-world patients with the ...

Exercise is guideline-recommended for patients with osteoarthritis of the knee, although comparative benefits from specific ...

Event-free survival (EFS) improved by 60% and overall survival (OS) by 50% with the antibody-drug conjugate (ADC) enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) versus upfront radical ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable ...

The latest in a series of randomized controlled trials investigating the potential of mass azithromycin administration to ...

Across several clinical outcomes, including 28-day mortality, beta-blocker esmolol was more effective than standard care and ...

At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing loca ...

With age comes wisdom. And wrinkles. And joint pain. In wellness circles, the buzz is that collagen supplements can help with ...

Sepsis remains one of the leading causes of mortality in hospitalized patients worldwide, and innovative therapeutic ...

The benefits of martial arts training in older adults can be further enhanced by the use of traditional weapon tools.

The ACHIEVE-5 trial (ClinicalTrials.gov identifier: NCT06109311) was a randomized, double-blind, placebo-controlled study that included 546 T2D patients with inadequate glycemic control on insulin ...

Trials should assess overall survival to evaluate potential harm, with crossover limited to avoid confounding treatment ...